NanJing Pharmaceutical Co Ltd
SSE:600713
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
NanJing Pharmaceutical Co Ltd
NanJing Pharmaceutical Co Ltd
Other Liabilities
NanJing Pharmaceutical Co Ltd
Other Liabilities Peer Comparison
1099
601607
600998
000963
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
NanJing Pharmaceutical Co Ltd
SSE:600713
|
Other Liabilities
¥297.1m
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
6%
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Other Liabilities
¥3.9B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
20%
|
CAGR 10-Years
12%
|
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Other Liabilities
¥922.5m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Other Liabilities
¥360.7m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
23%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Other Liabilities
¥793.6m
|
CAGR 3-Years
43%
|
CAGR 5-Years
32%
|
CAGR 10-Years
17%
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Other Liabilities
¥362.7m
|
CAGR 3-Years
33%
|
CAGR 5-Years
2%
|
CAGR 10-Years
33%
|
See Also
What is NanJing Pharmaceutical Co Ltd's Other Liabilities?
Other Liabilities
297.1m
CNY
Based on the financial report for Mar 31, 2024, NanJing Pharmaceutical Co Ltd's Other Liabilities amounts to 297.1m CNY.
What is NanJing Pharmaceutical Co Ltd's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
6%
Over the last year, the Other Liabilities growth was -1%. The average annual Other Liabilities growth rates for NanJing Pharmaceutical Co Ltd have been 3% over the past three years , 2% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
